Phreesia, Inc.

NYSE:PHR

Medical - Healthcare Information Services

Healthcare
$12.26 +0.80%

+$0.08 today

Market cap
$760.99M
Beta
0.88
P/E (TTM)
62.6
EPS (TTM)
$0.15
52W Low $7.77High $32.76

Volume 0.86M

Average 1.97M

PHR Weighted Avg Shares

Average number of basic shares outstanding during the period, used to calculate basic EPS.

Phreesia, Inc.NYSE: PHR

Weighted Avg Shares · Q1 FY2027 · quarter ended Apr 2026

Weighted avg shares grows in line with its trailing trend

Q1 FY2027 weighted avg shares of 60.94M shares rose 3.4% year over year, in line with the +3.0% change in trailing-twelve-month weighted avg shares. Sequentially, it rose 2.0% from the prior quarter. Over 3 fiscal years it compounded at +4.4% a year.

Context

  • Weighted avg shares increased in 3 of the last 3 fiscal years.
  • FY2026 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of +3.4% holds above the trailing-twelve-month pace of +3.0%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterApr 2026
60.94M+2.0% QoQ
Last fiscal yearJan 2026
59.74M+3.7% YoY
LTMApr 2026
59.86M+3.0% YoY
Weighted Avg Shares past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+3.4%——
1 year+3.7%——
3-year CAGR+4.4%——
5-year CAGR——
10-year CAGR——

Weighted Avg Shares history

Shares · from the income statement

Latest · FY2026
59.74M USD
Year-over-year change
+3.7%
4-year CAGR
+4.6%

Weighted Avg Shares vs competitors

How PHR compares with its peers on the latest reported figures

  • PHR's LTM Apr 2026 weighted avg shares of 59.86M shares is the 6th highest of the 11 companies compared; the peer median is 65.58M shares.
  • Its year-over-year change of +3.0% is the 4th highest of 11, against a peer median of +2.0%.
  • Over three fiscal years its annual growth of +4.4% compares with a peer median of +2.1%.
PHR Competitors Peer median
Weighted Avg Shares for PHR and competitors
Company Period LTM YoY 3-year CAGR
GDRXGoodRx Holdings, Inc.LTM Mar 2026346.3M -8.7%-4.8%
NEOGNeogen CorporationLTM Aug 2026217.73M +0.3%+4.8%
TDOCTeladoc Health, Inc.LTM Mar 2026176.73M +2.8%+3.0%
NVCRNovoCure LimitedLTM Mar 2026112.28M +3.5%+2.1%
SDGRSchrödinger, Inc.LTM Sep 202674.25M +1.4%+1.1%
PHRPhreesia, Inc.LTM Apr 202659.86M +3.0%+4.4%
OMDAOmada HealthLTM Mar 202656.91M +2.1%+1.6%
KMTSKestra Medical Technologies, Ltd.LTM Jan 202651.26M +3.5%—
BLFSBioLife Solutions, Inc.LTM Mar 202647.98M +3.2%+4.0%
OMCLOmnicell, Inc.LTM Mar 202645.65M -1.2%+1.2%
ESTAEstablishment Labs Holdings Inc.LTM Sep 202629.95M +1.9%+6.6%
Peer median (excluding PHR) 65.58M+2.0%+2.1%

Competitors are the stored peer set for PHR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2022
Jan 2022
FY2023
Jan 2023
FY2024
Jan 2024
FY2025
Jan 2025
FY2026
Jan 2026
Revenue213.23M280.91M356.3M419.81M480.59M
Cost of Revenue81.39M109.27M124.01M134.93M154.12M
Gross Profit131.85M171.64M232.29M284.88M326.47M
Gross Margin61.8%61.1%65.2%67.9%67.9%
Research & Development52.27M91.24M112.35M117.36M121.48M
Selling, General & Admin175.1M231.65M226.93M197.73M180.15M
Operating Expenses248.66M348.2M368.77M342.98M333.08M
Depreciation & Amortization24.52M28.77M30.54M27.89M31.45M
EBITDA(92.3M)(145.48M)(102.95M)(25.58M)29.47M
EBITDA Margin-43.3%-51.8%-28.9%-6.1%6.1%
Operating Income(116.82M)(176.55M)(136.48M)(58.1M)(6.61M)
Operating Margin-54.8%-62.9%-38.3%-13.8%-1.4%
Interest Income79K2.48M4.07M2.68M2.17M
Interest Expense1.16M1.41M1.85M2.35M6.95M
Other Income / Expenses(1.16M)889K1.14M2.29M(2.33M)
Income Before Tax(117.98M)(175.66M)(135.34M)(55.81M)(8.94M)
Pre-Tax Margin-55.3%-62.5%-38.0%-13.3%-1.9%
Income Tax Expense182K483K1.54M2.72M(11.25M)
Net Income(118.16M)(176.15M)(136.89M)(58.53M)2.31M
Net Margin-55.4%-62.7%-38.4%-13.9%0.5%
EPS (Basic)(2.37)(3.36)(2.51)(1.02)0.04
EPS (Diluted)(2.37)(3.36)(2.51)(1.02)0.04
Weighted Avg Shares49.89M52.44M54.56M57.59M59.74M
Weighted Avg Shares (Diluted)49.89M52.44M54.56M57.59M61.49M

Phreesia, Inc.

NYSE:PHR

Intrinsic Alpha fair value

Locked

Current Price

$12.26

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.